Orca Capital AG - 14 Apr 2025 SCHEDULE 13G Report for Can-Fite BioPharma Ltd. Ordinary Shares, no par value (CANF)

Filing Manager: Orca Capital AG
Reporting Manager: Orca Capital AG
Security: Can-Fite BioPharma Ltd. Ordinary Shares, no par value
Symbol: CANF
Shares outstanding: 3,865,979,381 shares
Disclosed Ownership: 375,000,000 shares
Ownership: 9.7%
Form type: SCHEDULE 13G
Filing time: 16 Apr 2025, 16:30:03 UTC
Date of event: 14 Apr 2025
Next filing: 23 Apr 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Orca Capital AG	9.7%	375,000,000	375,000,000	0	/s/ Thomas Konig	Thomas Konig/Director